An estimate of the annual direct cost of treating cutaneous melanoma

Journal of the American Academy of Dermatology

Volumn 38, Issue 5 I, 1998, Pages 669-680

  Tsao, H ^a   Rogers, G S ^a   Sober, A J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE SYSTEM; MELANOMA; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0031949429     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70195-1     Document Type: Article

References (36)

1. D Rigel Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis and treatment CA Cancer J Clin 46 1996 195 198
2. SL Parker T Tony S Bolden PA Wingo Cancer statistics, 1997 CA Cancer J Clin 47 1997 5 27
3. CM Balch SJ Soong HM Shaw MM Urist WH McCarthy An analysis of prognostic factors in 8500 patients with cutaneous melanoma CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 165 187
4. HK Koh Cutaneous melanoma N Engl J Med 325 1991 171 182
5. VA Albert HK Koh AC Geller DR Miller MN Prout RA Lew Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society J Am Acad Dermatol 23 1990 308 310
6. DA Lieberman Cost-effectiveness model for colon cancer screening Gastroenterology 109 1995 1781 1790
7. R Carter R Glasziou G van Oortmarssen Cost-effectiveness of mammographic screening in Australia Aust J Public Health 17 1993 42 50
8. T Byers R Gorsky Estimates of costs and effects of screening for colorectal cancer in the United States Cancer 70 1992 1288 1295
9. CM Coley MJ Barry C Fleming MC Fahs AG Mulley Early detection of prostate cancer. Part II: estimating the risks, benefits, and costs Ann Intern Med 126 1997 468 479
10. WH Clark Jr DE Elder D.IV Guerry Model predicting survival in stage I melanoma based on tumor progression J Natl Cancer Inst 81 1989 1893 1904
11. M Berwick CB Begg JA Fine GC Roush RL Barnhill Screening for cutaneous melanoma by skin self-examination J Natl Cancer Inst 88 1996 17 23
12. 3rd ed B Spiessl OH Beahrs P Hermanek UICC TNM atlas: illustrated guide to the TNM/pTNM classification of malignant tumors 1989 Springer-Verlag Berlin 163
13. N Provost AA Marghoob AW Kopt M DeDavid Q Wasti RS Bart Laboratory and imaging studies in patients with cutaneous malignant melanomas: a survey of experienced physicians J Am Acad Dermatol 36 1997 711 720
14. DL Morton DR Wen JH Wong JS Economou Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 1992 392 399
15. LF Glass NA Fenske J Messina The role of selective lymphadenectomy in the management of patients with malignant melanoma Dermatologic Surg 21 1995 979 983
16. DN Krag SJ Meijer DL Weaver Minimal access surgery for staging of malignant melanoma Arch Surg 130 1995 654 658
17. BW Hancock S Ahmedzai D Clark Palliative care of patients with terminal cancer Curr Opin Oncol 5 1993 655 660
18. D Gray D MacAdam D Boldy A comparative cost analysis of terminal cancer care in home hospice patients and controls J Chron Dis 40 1987 801 810
19. V Ventafridda F De Conno A Vigano C Ripamonti M Gallucci A Gamba Comparison of home and hospital care of advanced cancer patients Tumori 75 1989 619 625
20. CM Balch AC Buzaid Finally, a successful adjuvant therapy for high-risk melanoma J Clin Oncol 14 1996 1 3
21. WK Evans BP Will JM Berthelot MC Wolfson The economics of lung cancer management in Canada Lung Cancer 14 1996 19 20
22. N Basseres JJ Grob MA Richard X Thirion H Zarour C Noe Cost effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 191 1995 199 203
23. GH Limpert Skin cancer screening: a three-year experience that paid for itself J Fam Pract 40 1995 471 475
24. J Austoker Melanoma: prevention and early diagnosis BMJ 308 1994 1682 1686
25. ET Creagan Malignant melanoma: cost and reimbursement issues Sem Oncol 16 suppl 1989 45 50
26. A Girgis P Clarke RC Burton RW Sanson-Fisher Screening for melanoma by primary health care physicians: a cost effectiveness analysis J Med Screen 3 1996 47 53
27. RM MacKie D Hole Audit of public education campaign to encourage earlier detection of malignant melanoma BMJ 304 1992 1012 1015
28. GD Masri WH Clark Jr D.VI Guerry A Halpern CJ Thompson DE Elder Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease J Am Acad Dermatol 22 1990 1042 1048
29. DiGuiseppi C. Screening for skin cancer—including counseling to prevent skin cancer. Guide to Clinical Preventive Service (U.S. Government). (text.nlm.nih.gov/cps/www/cps.18.html)
30. CM Balch SJ Soong HM Shaw Changing trends in clinical and pathological features of melanoma CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 165 187
31. JM Kirkwood MH Strawderman MS Ernstoff TJ Smith EC Borden RH Blum Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern cooperative oncology group trial EST 1684 J Clin Oncol 14 1996 7 17
32. MF Demierre HK Koh Adjuvant therapy for cutaneous malignant melanoma J Am Acad Dermatol 36 1997 747 764
33. AN Houghton S Legha DF Bajorin Chemotherapy for metastatic melanoma CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 498 508
34. DR Parkinson AN Houghton P Hersey EC Borden Biologic therapy for melanoma CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 522 541
35. AN Houghton CM Balch Treatment for advanced disease CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 468 497
36. J Ziegler New database allows researchers to evaluate cancer care costs J Natl Cancer Inst 85 1993 351